{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Calculate the Likelihood of Biomarker Measurements {#sec-calc-ll}\n",
    "\n",
    "Suppose we have a participant's data, for example, @fig-sample-data. Now, the question is:\n",
    "\n",
    ">What is the likelihood of this participant having this sequence of biomarker data, given that we know $S, \\theta, \\phi$.\n",
    "\n",
    "In the following, we explain how to calculate this likelihood in two scenartios: (1) known $k_j$ and (2) unknown $k_j$.\n",
    "\n",
    "## Known $k_j$\n",
    "\n",
    "$$\n",
    "p(X_{j} | S, z_j = 1, k_j) = \\underbrace{\\prod_{i=1}^{k_j}{p(X_{S(i)j} \\mid \\theta_{S(i)} )}}_{\\text{Affected biomarker likelihood}} \\, \n",
    "\\underbrace{\\prod_{i=k_j+1}^N{p(X_{S(i)j} \\mid \\phi_{S(i)})}}_{\\text{Non-affected biomarker likelihood}}\n",
    "$$ {#eq-known-kj}\n",
    "\n",
    "This equation compuates the likelihood of the observed biomarker data of a specific participant, given that we know the disease stage this patient is at ($k_j$). \n",
    "\n",
    "- $S$ is an **orded array** of biomarkers that are affected by the disease, for example, $[b, a, d, c]$. This means that biomarker $b$ is affected at stage 1. At stage 2, biomarker $b$ and $a$ will be affected. \n",
    "\n",
    "- $S(i)$ is the $i^{th}$ biomarker according to $S$. For example $S_1$ will be biomarker $b$. \n",
    "\n",
    "- $k_j$ indicates the stage the patient is at, for example, $k_j = 2$. This means that the disease has effected biomarker $a$ and $b$. Biomarker $c$ and $d$ have not been affected yet. \n",
    "\n",
    "- $\\theta_{S(i)}$ is the parameters for the probability density function (PDF) of observed value of biomarker $S(i)$ when this biomarker has been affected by the disease. Let's assume this distribution is a Gaussian distribution with means of $[45, 50, 55, 60]$ and a standard deviation of $5$ for biomarker $b$, $a$, $d$, and $c$. \n",
    "\n",
    "- $\\phi_{S(i)}$ is the parameters for the probability density function (PDF) of observed value of biomarker $S(i)$ when this biomarker has **NOT** been affected by the disease. Let's assume this distribution is a Gaussian distribution with means of $[25, 30, 35, 40]$ and a standard deviation of $3$ for biomarker $b$, $a$, $d$, and $c$.\n",
    "\n",
    "- $X_j$ is an array representing the patient's observed data for all biomarker. Assume the data is $[77, 45, 53, 90]$ for biomarker $b$, $a$, $d$, and $c$.\n",
    "\n",
    "We assume that the patient is at stage $2$ of this disease; hence $k_j = 2$. \n",
    "\n",
    "Next, we are going to calculate $p(X_j|S, z_j = 1, k_j)$:\n",
    "\n",
    "When $i = 1$, we have $S_{(i)} = b$ and $X_{S_{(i)}} = X_b = 45$. So\n",
    "\n",
    "$$p(X_{S_{(i)}} | \\theta_{S(i)}) = \\frac{1}{\\sigma \\sqrt{2 \\pi}} e^{-\\frac{1}{2}\\left(\\frac{X_b - \\mu}{\\sigma} \\right)^2}$$\n",
    "\n",
    "Because $k_j = 2$, so biomarker $b$ and $a$ are affected. We should use the distribution of $\\theta_b$; therefore, we should plug in $\\mu = 45, \\sigma = 5$ in the above equation. \n",
    "\n",
    "We can do the same for $i$ = 2, 3, and 4. \n",
    "\n",
    "So\n",
    "\n",
    "$$p(X_j | S, k_j = 2) = p (X_b | \\theta_b) \\times p (X_a | \\theta_a) \\times p (X_d | \\phi_d) \\times p (X_c | \\phi_c)$$\n",
    "\n",
    "The above is the likelihood of the given biomarker data when $k_j = 2$.\n",
    "\n",
    "Note that $p (X_b | \\theta_b)$ is probability density, a value of a probability density function at a specific point; so it is not a probability itself. \n",
    "\n",
    "**Multiplying multiple probability densities will give us a likelihood**. \n",
    "\n",
    "## Unknown $k_j$\n",
    "\n",
    "$$\n",
    "P(X_{j} | S) = \\sum_{k_j=0}^N{P(k_j) p(X_{j} \\mid S, k_j)}\n",
    "$$ {#eq-unknown-kj}\n",
    "\n",
    "Suppose we have the same information above, except that we do not know at which disease stage the patient is, i.e., we do not know $k_j$. We have the observed biomarker data: $X_j = [77, 45, 53, 90]$. And I wonder: what is the likelihood of seeing this specific ovserved data?\n",
    "\n",
    "We assume that all five stages (including $k_j = 0$) are equally likely. \n",
    "\n",
    "We do not know $k_j$, so the best option is to calculate the \"average\" likelihood of all the biomarker data. \n",
    "\n",
    "Based on @eq-known-kj, we can calculate the following:\n",
    "\n",
    "$L_1 = p(X_j | S, k_j = 1)$\n",
    "\n",
    "$L_2 = p(X_j | S, k_j = 2)$\n",
    "\n",
    "$L_3 = p(X_j | S, k_j = 3)$\n",
    "\n",
    "$L_4 = p(X_j | S, k_j = 4)$\n",
    "\n",
    "If this participant is healthy, then we know $k_j = 0$, therefore:\n",
    "\n",
    "$$L = L_0 = p(X_j | S, k_j = 0) = p (X_b | \\phi_b) \\times p (X_a | \\phi_a) \\times p (X_d | \\phi_d) \\times p (X_c | \\phi_c)$$\n",
    "\n",
    "If this participant is diseased but we do not know the actual $k_j$, we can estimate it this way\n",
    "\n",
    "$$L_1 = p(X_j | S, k_j = 1) = p (X_b | \\theta_b) \\times p (X_a | \\phi_a) \\times p (X_d | \\phi_d) \\times p (X_c | \\phi_c)$$\n",
    "\n",
    "$$L_2 = p(X_j | S, k_j = 2) = p (X_b | \\theta_b) \\times p (X_a | \\theta_a) \\times p (X_d | \\phi_d) \\times p (X_c | \\phi_c)$$\n",
    "\n",
    "$$L_3 = p(X_j | S, k_j = 3) = p (X_b | \\theta_b) \\times p (X_a | \\theta_a) \\times p (X_d | \\theta_d) \\times p (X_c | \\phi_c)$$\n",
    "\n",
    "$$L_4 = p(X_j | S, k_j = 4) = p (X_b | \\theta_b) \\times p (X_a | \\theta_a) \\times p (X_d | \\theta_d) \\times p (X_c | \\theta_c)$$\n",
    "\n",
    "$P(k_j)$ is the prior likelihood of being at stage $k$. **Event based models assume a uniform prior on $k_j$**. Therefore:\n",
    "\n",
    "$P(X_{j} | z_j=1, S) = \\frac{1}{4} \\left(L_1 + L_2 + L_3 + L_4 \\right)$"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    ":::{.callout-tip}\n",
    "\n",
    "When this participant is diseased but we do not know the actual stage of this participant, the above method is useful also because it hints at the relative likelihood of each possible stage. For example, if L2 is much larger than L1, L3, and L4, then we know this participant is most likely to be at stage 2. \n",
    "\n",
    ":::"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Extension \n",
    "\n",
    "If we are more interested in the likelihood of a whole dataset consisting of all participants, we multiply all participants' likelihood: $L = L_{P_1} \\times L_{P_2} \\times L_{P_3} ... \\times L_{P_j}$. Because this number tends to be very large, we take the natural log of $L$, i.e., $\\ln(L)$."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "bayes",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "name": "python",
   "version": "3.8.19"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
